"Triarco Industries announced today new clinical findings which suggest Aminogen® may help support measures of cardiovascular health, such as cholesterol and triglyceride levels. An earlier clinical study, published in the Journal of the International Society of Sports Nutrition, found that Aminogen® significantly lowered C - reactive protein (CRP), an indication of cardiovascular inflammation, by 10 percent. Taken together, Triarco scientists say these results may position Aminogen® as a strong player in the booming cardiovascular health market."